Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
RETINA
Publication-derived

Retinal Organoids for Drug Screening and Infection (RT-TX-21)

Source Völkner et al., 2021 · German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany · DOI

Duration: 225 days Cell source: Human iPSC Full SOP · 9 phases · QC included
Drug screening
RT-TX-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Amyotrophic Lateral Sclerosis Brain Organoids (BN-DS-23)

Source Tamaki et al., 2023 · Montreal Neurological Institute-Hospital, McGill University · DOI

Duration: 116 days Cell source: Human iPSC (from peripheral blood mononuclear cells; ALS patient and healthy control derived) Full SOP · 9 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Metastatic Colorectal Cancer Colonic Tumouroids (IN-CA-19)

Source Ooft et al., 2019 · Netherlands Cancer Institute, Amsterdam · DOI

Duration: 20 days Cell source: Patient-Derived Tumor Organoids (PDOs) from metastatic colorectal cancer lesions Full SOP · 6 phases · QC included
Drug screening
IN-CA-19 Full SOP with Academic or a plan
PANCREAS
Publication-derived

Pancreatic Intraepithelial Neoplasia Organoids (PN-DS-17)

Source Lee et al., 2017 · Stanford University School of Medicine, Department of Developmental Biology · DOI

Duration: 240 days Cell source: Human primary pancreatic duct cells (CD133+), healthy cadaveric donors Full SOP · 9 phases · QC included
Disease modelling
PN-DS-17 Full SOP with Academic or a plan
BRAIN
Publication-derived

Hypoxic-Ischaemic Stroke Brain Organoids (BN-DS-20)

Source Nzou et al., 2020 · Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine · DOI

Duration: 21 days Cell source: Human iPSC-derived cells (oligodendrocytes, microglia, neural stem cells) and primary human cells (brain microvascular endothelial cells, pericytes, astrocytes) Full SOP · 12 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Hypoxic Brain Injury Organoids (BN-DS-21)

Source Kim et al., 2021 · Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University · DOI

Duration: 86 days Cell source: Human adult dermal fibroblast-derived neural stem cells (iNSCs) Full SOP · 4 phases · QC included
Drug screening
BN-DS-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Progressive Multifocal Leukoencephalopathy Cerebral Organoids (BN-DS-25)

Source Rocchi et al., 2025 · Temple University Lewis Katz School of Medicine, Department of Microbiology, Immunology and Inflammation, Center for Neurovirology and Gene Editing · DOI

Duration: 150 days Cell source: Human iPSC (cerebral organoid-derived) and SVG astrocytes Full SOP · 8 phases · QC included
Disease modelling
BN-DS-25 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Adenocarcinoma Intestinal Bioprinted and Engineered Tissues (IN-DS-19)

Source Creff et al., 2019 · LAAS-CNRS, Université de Toulouse, CNRS · DOI

Duration: 21 days Cell source: Caco-2 (human colorectal adenocarcinoma cells) Full SOP · 5 phases · QC included
Disease modelling
IN-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Choroid Plexus Organoids (BN-DS-20)

Source Jacob et al., 2020 · University of Pennsylvania, Perelman School of Medicine · DOI

Duration: 72 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Cortical Organoids with Astrocytes (BN-DS-22)

Source Andrews et al., 2022 · University of California, San Francisco · DOI

Duration: 5 days Cell source: Human iPSC and primary cortical tissue (developmental and adult) Full SOP · 9 phases · QC included
Disease modelling
BN-DS-22 Full SOP with Academic or a plan
BRAIN
Publication-derived

Huntington's Disease Striatal Assembloids (BN-DS-24)

Source Wu et al., 2024 · Nanjing Medical University · DOI

Duration: 80 days Cell source: Human iPSC, Patient-Derived iPSC (Huntington's disease) Full SOP · 12 phases · QC included
Disease modelling
BN-DS-24 Full SOP with Academic or a plan
SKIN
Publication-derived

Merkel Cell Carcinoma Skin Tumouroids (SK-DS-22)

Source Forsythe et al., 2022 · Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine · DOI

Duration: 10 days Cell source: Patient-Derived Tumor Cells Full SOP · 5 phases · QC included
Drug screening
SK-DS-22 Full SOP with Academic or a plan
BRAIN
Publication-derived

Prenatal Hypoxic Injury Brain Organoids (BN-DS-19)

Source Daviaud et al., 2019 · Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai · DOI

Duration: 42 days Cell source: Human ESC (H9) Full SOP · 5 phases · QC included
Disease modelling
BN-DS-19 Full SOP with Academic or a plan
OTHER
Publication-derived

Organoids for Drug Screening (2018)

Source Drost et al., 2018 · Princess Máxima Centre for Paediatric Oncology and Hubrecht Institute, Utrecht, Netherlands · DOI

Duration: 21 days Cell source: Patient-Derived Tumor Tissue (multiple cancer types) Full SOP · 8 phases · QC included
Drug screening
Full SOP with Academic or a plan
BRAIN
Publication-derived

Schizophrenia and Bipolar Disorder Cerebral Organoids (BN-DS-25)

Source Cheng et al., 2025 · Johns Hopkins University · DOI

Duration: 270 days Cell source: Patient-Derived iPSC (Schizophrenia, Bipolar Disorder) Full SOP · 15 phases · QC included
Disease modelling
BN-DS-25 Full SOP with Academic or a plan
SKIN
Publication-derived

Diabetic Wound Skin Organoids (SK-DS-25)

Source Zhixin et al., 2025 · Guangdong Medical University, The First Clinical Medical College · DOI

Duration: 92 days Cell source: Human iPSC Full SOP · 8 phases · QC included
Disease modelling
SK-DS-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Cortical Organoids for Drug Screening (BN-DS-22)

Source Mesci et al., 2022 · University of California San Diego · DOI

Duration: 52 days Cell source: Human iPSC Full SOP · 10 phases · QC included
Drug screening
BN-DS-22 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Drug Screening and Development (LV-DR-24)

Source Choi et al., 2024 · National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety · DOI

Duration: 10 days Cell source: Human iPSC Full SOP · 19 phases · QC included
Drug screening
LV-DR-24 Full SOP with Academic or a plan
BRAIN
Publication-derived

Bipolar Disorder Cerebral Organoids (BN-DS-25)

Source El Sabbagh et al., 2025 · University of Toronto, Krembil Brain Institute, Toronto Western Hospital, University Health Network · DOI

Duration: 180 days Cell source: Patient-Derived iPSC (Bipolar Disorder) Full SOP · 11 phases · QC included
Disease modelling
BN-DS-25 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Toxicity Testing and Disease Modelling (LV-DS-23)

Source Cheng et al., 2023 · Shanghai Jiao Tong University School of Medicine · DOI

Duration: 27 days Cell source: Human ESC (H1 ES, WA01) Full SOP · 10 phases · QC included
Safety & toxicology
LV-DS-23 Full SOP with Academic or a plan
LIVER
Publication-derived

Steatohepatitis Liver Organoids for Disease Modelling (LV-DS-22)

Source Kimura et al., 2022 · Cincinnati Children's Hospital Medical Center · DOI

Duration: 30 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Disease modelling
LV-DS-22 Full SOP with Academic or a plan
LIVER
Publication-derived

Primary Sclerosing Cholangitis Biliary Organoids (LV-DS-24)

Source Moreno et al., 2024 · Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, Minnesota, USA · DOI

Duration: 15 days Cell source: Patient-Derived Cholangiocytes (Primary Sclerosing Cholangitis and Non-PSC Controls) Full SOP · 4 phases · QC included
Disease modelling
LV-DS-24 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Cystic Fibrosis Colonic Organoids (IN-DS-16)

Source Dekkers et al., 2016 · Wilhelmina Children's Hospital, University Medical Center Utrecht · DOI

Duration: 10 days Cell source: Patient-Derived Primary Rectal Epithelial Cells (Cystic Fibrosis) Full SOP · 4 phases · QC included
Drug screening
IN-DS-16 Full SOP with Academic or a plan
LIVER
Publication-derived

Fatty Liver Disease Organ-on-Chip Models (LV-DS-24)

Source Wang et al., 2024 · Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences · DOI

Duration: 30 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Drug screening
LV-DS-24 Full SOP with Academic or a plan